Filing Details
- Accession Number:
- 0001209191-17-047796
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-04 19:50:26
- Reporting Period:
- 2017-08-03
- Filing Date:
- 2017-08-04
- Accepted Time:
- 2017-08-04 19:50:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1510580 | Kite Pharma Inc. | KITE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1669207 | L. Timothy Moore | C/O Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica CA 90404 | Evp, Technical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-03 | 6,000 | $44.91 | 55,400 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-08-03 | 869 | $110.10 | 54,531 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-08-03 | 5,131 | $110.05 | 49,400 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2017-08-03 | 6,000 | $0.00 | 6,000 | $44.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 146,000 | 2026-03-14 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 30, 2017.
- 25% of the 155,000 shares subject to the stock option vested and became exercisable on March 15, 2017, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
